Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
12,179,959
-
Share change
-
+4,201,081
-
Total reported value
-
$574,089,000
-
Price per share
-
$47.15
-
Number of holders
-
60
-
Value change
-
+$198,056,631
-
Number of buys
-
41
-
Number of sells
-
5
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2020
As of 31 Dec 2020 NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,179,959 shares of stock of the company.
Largest 10 holders included Cederberg Capital Ltd, Avidity Partners Management LP, HILLHOUSE CAPITAL ADVISORS, LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., Artisan Partners Limited Partnership, Ward Ferry Management (BVI) Ltd, MANUFACTURERS LIFE INSURANCE COMPANY, THE, ORBIMED ADVISORS LLC, Octagon Capital Advisors LP, and Bellevue Group AG.
This table shows 60 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.